SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-20-000853
Filing Date
2020-02-14
Accepted
2020-02-14 16:01:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP sesna1_21420.htm SC 13G/A 53461
  Complete submission text file 0001085146-20-000853.txt   55101
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87951 | Film No.: 20619219
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

IRS No.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A